Lung microbiome, gut-lung axis and chronic obstructive pulmonary disease

Area of Science:

• Pulmonary medicine
• Microbiology
• Gastroenterology

Background:

• The lung microbiome is dynamic and influenced by pulmonary inflammation.
• Chronic obstructive pulmonary disease (COPD) is characterized by lung inflammation and injury.
• The gut-lung axis describes the bidirectional communication between the gastrointestinal tract and the lungs.

Purpose of the Study:

• To review current data on lung microbiome alterations in COPD.
• To explore the role of the gut-lung axis in COPD pathogenesis.
• To identify potential new therapeutic targets for COPD.

Main Methods:

• Literature review of recent studies on COPD, lung microbiome, and gut-lung axis.
• Analysis of data on the interplay between lung inflammation and microbial shifts.
• Examination of evidence linking gastrointestinal changes to COPD progression.

Main Results:

• Lung inflammation in COPD alters the lung environment, promoting a shift in the lung microbiome.
• The evolving lung microbiome in COPD appears to participate in inflammatory processes and lung destruction.
• COPD is associated with increased intestinal permeability and alterations in the gut microbiome, suggesting a role for the gut-lung axis.

Conclusions:

• The lung microbiome plays a role in COPD pathogenesis, distinct from its role in healthy lungs.
• The gastrointestinal tract may contribute to the inflammatory processes driving COPD progression.
• Understanding the gut-lung axis in COPD may reveal novel therapeutic strategies.